Career history of George W. Koszalka
Former positions of George W. Koszalka
| Companies | Position | Start | End |
|---|---|---|---|
NeurOp, Inc.
 NeurOp, Inc. Pharmaceuticals: MajorHealth Technology NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and alzheimer's and parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA. | Director/Board Member | 2010-01-31 | 2017-09-30 |
| Chief Executive Officer | 2011-06-06 | 2017-09-30 | |
| President | 2011-06-06 | 2017-09-30 | |
Argolyn Bioscience, Inc.
 Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | Corporate Officer/Principal | 2009-05-25 | 2009-11-25 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - | - |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Corporate Officer/Principal | - | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - | - |
The Burroughs Wellcome Fund
 The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Corporate Officer/Principal | - | - |
Training of George W. Koszalka
| North Carolina State University | Doctorate Degree |
Statistics
International
| United States | 8 |
Operational
| Corporate Officer/Principal | 5 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 6 |
| Miscellaneous | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | Health Technology |
NeurOp, Inc.
NeurOp, Inc. Pharmaceuticals: MajorHealth Technology NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and alzheimer's and parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA. | Health Technology |
The Burroughs Wellcome Fund
The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Miscellaneous |
| Glaxo Wellcome, Inc. | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- George W. Koszalka
- Experience
